(Day 2) Bangkok Summit: Prof. Mike Chan Calls for Precision Cell Therapies to Tackle ‘Untreatable’ Diseases

BANGKOK, Thailand (Nov 10, 2025) — On Day 2 of the We Are The World Global Summit, one speaker once again drew the crowd: Prof. Dato’ Sri Dr. Mike Chan, Chairman of the European Wellness Biomedical Group and one of the world’s most prominent voices in regenerative medicine.  Prof. Chan delivered a commanding two-part presentation that pushed the boundaries of conventional anti-aging and neuroregenerative science.

Precision Over Generalization: The New Rule in Neurodegeneration

In the first session, Prof. Chan challenged long-held assumptions about stem cell therapy, arguing that generalized cell approaches are inadequate for complex neurodegenerative and autoimmune diseases.

He warned that the common practice of injecting multipotent mesenchymal cells (tissue cells) into patients with multi-system disorders is scientifically flawed.

“Alzheimer’s does not only need pancreatic Islet cells. It needs cells for the frontal lobe. Parkinson’s needs the substantia nigra. Autism requires both intestinal mucosa and brain precursors. You do not simply inject one type of stem cell and expect it to treat everything,” he said.

He offered a powerful analogy:

“You give A1 for A1 disease, B6 for B6 disease, Z10 for Z10 disease. You cannot give ‘A’ and claim it treats diabetes, autism, Alzheimer’s, Parkinson’s, cancer and everything else. Bio-regenerative medicine is about specificity and precision.”

Prof. Chan emphasized unipotent precursor cells as the correct therapeutic direction for organs such as the brain, kidney, and heart—systems that require highly specialized cellular targeting to regenerate.

Battling Biological Age and Organ Decay

The professor then shifted to the central question of aging: not how long we live, but how well we function while living.

At age 64, his biological age measured just 46—an 18-year reversal. Prof. Chan shared that he has maintained this biological age consistently for three years in a row. Drawing from his own results, he explained that today, reversing biological age by six to 18 years is a realistic and achievable outcome when treatments are precisely targeted to each organ’s timeline of deterioration.

Most organs, he noted, are not biologically designed to last 100 years, much less 120. The pancreas begins aging at 55, the heart at around 40, the lungs at 20, and the brain shows accelerated decline after 65.

He offered a simple yet potent intervention: consuming raw fruits or plain salad before heavy meals to reduce strain on the pancreas and prolong its functional life.

Unmasking the Hidden Roots of Autism and Mental Health Disorder

A significant segment of the talk focused on rising neurodevelopmental disorders across Asia.

Prof. Chan revealed that a large number of autistic children treated at his centers showed two consistent issues:

1. Severe gut dysfunction
2. Heavy metal accumulation

“Your gut has more brain cells than your brain. If you do not fix the gut, you cannot fix the child,” he said.

He explained that autism treatment must combine:

• Stem cells or peptides of the intestinal mucosa
• Brain-specific precursors targeting the frontal lobe, hippocampus, and cortex

Beyond the biology, Prof. Chan highlighted a pressing social crisis: the psychological collapse of parents caring for autistic children. He referenced a tragic case in Singapore where a father killed his two sons under immense stress.

“The hardest patients are not the children. It is the parents. Ninety percent of the time, it is the mothers. They do not sleep. They carry the burden alone,” he said.

The Future Is Fetal – And the Future Is Asian

Prof. Chan reaffirmed his scientific stance that the safest and most effective stem cells are from the fetal stage—never from human fetuses, but from ethically compliant, virus-free, pre-birth organ tissues at the ideal stage of differentiation.

Aligning with his Roman Catholic principles and international biomedical rules, he strongly condemned the use of human fetuses and clarified that his group works strictly with legal, regulated, and ethically approved sources.

He also described the strategic shift of global biomedical growth toward Asia.

“The purchasing power is here. The future of regenerative medicine is here,” he said, noting that while his manufacturing remains in Switzerland and Germany, his research, clinical reach, and market engagement are shifting to Asia and the Middle East.

Prof. Chan’s Day 2 presentations attracted considerable attention within the Summit, drawing other health experts and delegates to hear his perspectives on regenerative and neurodegenerative medicine.

Attendees paid close attention to his explanations on aging hallmarks, immune reconstruction, metabolic correction, peptide bioregulation, and targeted neuro-therapy.

His detailed, evidence-based approach was well received. With clarity, provocation, and clinical evidence, Prof. Chan delivered what many delegates described as one of the strongest scientific sessions of the Summit.